Icecure Medical is trading 6.32% up at $2.24 after rising from the September 9 close of $2.11; the catalyst remains unconfirmed.
- No reliable September 10, 2026 company-specific announcement, earnings release, or regulatory catalyst was identified.
- The latest investor-relations items available were dated August 2026.
- Healthcare futures are lower and major indexes are mixed, so broader market conditions do not clearly explain the isolated pre-market gain.